Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar
As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science. To explore these advancements, Insilico Medicine (03696.HK), a clinical-stage generative AI–driven drug discovery company, today announced that the Pharma.AI Spring Kickoff 2026 will be held…
